GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa

Go back to GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa
AGENUS (NASDAQ: AGEN) Delayed: 7.61 -0.63 (7.65%)
Previous Close $8.24    52 Week High $7.49 
Open $8.14    52 Week Low $2.61 
Day High $8.18    P/E N/A 
Day Low $7.59    EPS $-1.10 
Volume 773,958       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 48.66 -1.23 (2.47%)
Previous Close $49.89    52 Week High $45.58 
Open $49.00    52 Week Low $37.82 
Day High $49.23    P/E N/A 
Day Low $48.54    EPS $0.00 
Volume 2,259,802